Physician profile
Andrea R Dunkelman
NPI 1225087182
$72,858.41
in general payments reported to CMS, 2019-2025
20 companies · $4,132 in 2025
The $4,132 reported for 2025 was more than what 91% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $818 · 2020: $671 · 2021: $19K · 2022: $25K · 2023: $12K · 2024: $11K · 2025: $4,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $5,941 · Education: $1,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,300.00 |
| Food and Beverage | $5,941.25 |
| Education | $1,025.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $35,701.94 | 2021-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Community Blood Center | $13,279.16 | 2021-2025 | |
| Smith+Nephew, INC. | $11,809.29 | 2019-2025 | Oasis, Grafix, Collagenase Santyl |
| Medline Industries Lp | $5,579.65 | 2019-2025 | |
| Kerecis Limited | $2,328.12 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Musculoskeletal Transplant Foundation INC. | $1,235.64 | 2020-2022 | |
| Aroa Biosurgery Incorporated | $982.86 | 2022-2025 | |
| Biotissue Holdings INC. | $723.48 | 2025 | |
| Avita Medical Americas, LLC | $306.92 | 2019-2021 | |
| Access Pro Medical, LLC | $192.42 | 2025 | Matriderm |
| Galderma Laboratories, L.P. | $146.22 | 2022-2024 | Dysport |
| Revance Therapeutics, INC. | $135.63 | 2024 | Daxxify |
| Merz North America, INC. | $96.87 | 2019 | |
| Integra Lifesciences Corporation | $79.19 | 2020-2022 | |
| Polynovo North America LLC | $70.13 | 2019-2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polymedics Innovations INC. | $67.71 | 2023 | |
| Vericel Corporation | $53.40 | 2025 | Nexobrid |
| Acell, INC. | $37.37 | 2019-2020 | |
| Polarityte, INC. | $16.64 | 2019 | |
| Medela LLC | $15.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Dunkelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.